NCT07172672Not yet recruiting
The TiMeD-T1D Project
Impact of Meal Insulin Dose Timing on Meal Fat Storage in Patients With Type 1 Diabetes: a Randomized Control Trial - the TiMeD-T1D Project
Source: ClinicalTrials.gov · Last updated 26 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of the proposed study is to investigate the metabolic consequences of varying the timing of meal insulin boluses and skipping boluses altogether in individuals with type 1 diabetes. The investigator hypothesize that delaying or skipping meal insulin boluses leads to greater ectopic fat storage due to a delayed stimulation of lipoprotein activity and delayed suppression of lipolysis and VLDL-TG secretion.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 8 Sept 2025
- Start date
- 1 Nov 2025
- Primary completion date
- 1 Feb 2027
- Lead sponsor
- University of Aarhus
- Diseases
- Type 1 diabetes
- NCT number
- NCT07172672
What you commit to
- Study type: Interventional
- Planned participants: 10
- From 1 Nov 2025 to the primary completion date, 1 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in other clinical trials involving ionized radiation within the last 6 months
Lab values
- Medicine with an impact on blood glucose or blood pressure
Other
- Affected screening blood sample as evaluated by the clinical responsible investigator.
- Alcohol or substance abuse
- BMI \> 35 kg/m2 or \< 18.5 kg/m2
- Lactose intolerance
- Doesn't speak and understand Danish.
- Severe claustrophobia.
- Commitment to special diets
Who the study is looking for
- Type 1 diabetes duration \> 3 years or c-peptide negative
- Written and informed consent
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Nuclear Medicine & PET-Centre, AUH Palle Juul-Jensens Blvd. 165, 8200 Aarhus N, Denmark and Medical Research Laboratories/Steno Diabetes Center Aarhus, AUH Palle Juul-Jensens Blvd. 11, 8200 Aarhus N, Denmark Coordinator of this site? Confirm its status | Aarhus | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.